Clinical Trial Update: Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Catheters [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of Alfimeprase in subjects with occluded catheters has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Catheter Occlusion
• Venous Thrombosis

Drugs mentioned

• Alfimeprase (alfimeprase)

Snippet

Sponsor: ARCA Biopharma, Inc. | Conditions: Thrombosis, Venous Thrombosis | Phase 3 | Status: COMPLETED